These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 17127070)

  • 1. Synthesis and evaluation of unsaturated caprolactams as interleukin-1beta converting enzyme (ICE) inhibitors.
    Wang Y; O'Neil SV; Wos JA; Oppong KA; Laufersweiler MC; Soper DL; Ellis CD; Baize MW; Fancher AN; Lu W; Suchanek MK; Wang RL; Schwecke WP; Cruze CA; Buchalova M; Belkin M; De B; Demuth TP
    Bioorg Med Chem; 2007 Feb; 15(3):1311-22. PubMed ID: 17127070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and evaluation of thiazepines as interleukin-1beta converting enzyme (ICE) inhibitors.
    Ellis CD; Oppong KA; Laufersweiler MC; O'Neil SV; Soper DL; Wang Y; Wos JA; Fancher AN; Lu W; Suchanek MK; Wang RL; De B; Demuth TP
    Bioorg Med Chem Lett; 2006 Sep; 16(18):4728-32. PubMed ID: 16870441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and evaluation of tricyclic pyrrolopyrimidinones as dipeptide mimetics: inhibition of interleukin-1beta-converting enzyme.
    Laufersweiler MC; Wang Y; Soper DL; Suchanek MK; Fancher AN; Lu W; Wang RL; Oppong KA; Ellis CD; Baize MW; O'Neil SV; Wos JA; Demuth TP
    Bioorg Med Chem Lett; 2005 Oct; 15(19):4322-6. PubMed ID: 16046129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enantio- and diastereoselective total synthesis of EI-1941-1, -2, and -3, inhibitors of interleukin-1beta converting enzyme, and biological properties of their derivatives.
    Shoji M; Uno T; Kakeya H; Onose R; Shiina I; Osada H; Hayashi Y
    J Org Chem; 2005 Nov; 70(24):9905-15. PubMed ID: 16292821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and evaluation of novel 1-(2-acylhydrazinocarbonyl)-cycloalkyl carboxamides as interleukin-1beta converting enzyme (ICE) inhibitors.
    Soper DL; Sheville J; O'Neil SV; Wang Y; Laufersweiler MC; Oppong KA; Wos JA; Ellis CD; Fancher AN; Lu W; Suchanek MK; Wang RL; De B; Demuth TP
    Bioorg Med Chem Lett; 2006 Aug; 16(16):4233-6. PubMed ID: 16782334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The design and synthesis of sulfonamides as caspase-1 inhibitors.
    Harter WG; Albrect H; Brady K; Caprathe B; Dunbar J; Gilmore J; Hays S; Kostlan CR; Lunney B; Walker N
    Bioorg Med Chem Lett; 2004 Feb; 14(3):809-12. PubMed ID: 14741295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Total synthesis of the interleukin-1beta converting enzyme inhibitor EI-1941-2 using tandem oxa-electrocyclization/oxidation1.
    Kleinke AS; Li C; Rabasso N; Porco JA
    Org Lett; 2006 Jun; 8(13):2847-50. PubMed ID: 16774272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and evaluation of novel 8,5-fused bicyclic peptidomimetic compounds as interleukin-1beta converting enzyme (ICE) inhibitors.
    Soper DL; Sheville JX; O'Neil SV; Wang Y; Laufersweiler MC; Oppong KA; Wos JA; Ellis CD; Baize MW; Chen JJ; Fancher AN; Lu W; Suchanek MK; Wang RL; Schwecke WP; Cruze CA; Buchalova M; Belkin M; Wireko F; Ritter A; De B; Wang D; Demuth TP
    Bioorg Med Chem; 2006 Dec; 14(23):7880-92. PubMed ID: 16908171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of novel conformationally restricted diazocan peptidomimetics as inhibitors of interleukin-1beta synthesis.
    Oppong KA; Ellis CD; Laufersweiler MC; O'Neil SV; Wang Y; Soper DL; Baize MW; Wos JA; De B; Bosch GK; Fancher AN; Lu W; Suchanek MK; Wang RL; Demuth TP
    Bioorg Med Chem Lett; 2005 Oct; 15(19):4291-4. PubMed ID: 16046125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Succinic acid amides as P2-P3 replacements for inhibitors of interleukin-1beta converting enzyme (ICE or caspase 1).
    Galatsis P; Caprathe B; Gilmore J; Thomas A; Linn K; Sheehan S; Harter W; Kostlan C; Lunney E; Stankovic C; Rubin J; Brady K; Allen H; Talanian R
    Bioorg Med Chem Lett; 2010 Sep; 20(17):5184-90. PubMed ID: 20656488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ICE/caspase 1 inhibitors and IL-1beta receptor antagonists as potential therapeutics in epilepsy.
    Vezzani A; Balosso S; Maroso M; Zardoni D; Noé F; Ravizza T
    Curr Opin Investig Drugs; 2010 Jan; 11(1):43-50. PubMed ID: 20047158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and evaluation of novel 8,6-fused bicyclic peptidomimetic compounds as interleukin-1beta converting enzyme inhibitors.
    O'Neil SV; Wang Y; Laufersweiler MC; Oppong KA; Soper DL; Wos JA; Ellis CD; Baize MW; Bosch GK; Fancher AN; Lu W; Suchanek MK; Wang RL; De B; Demuth TP
    Bioorg Med Chem Lett; 2005 Dec; 15(24):5434-8. PubMed ID: 16216507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery, synthesis and biological evaluation of isoquinolones as novel and highly selective JNK inhibitors (1).
    Asano Y; Kitamura S; Ohra T; Aso K; Igata H; Tamura T; Kawamoto T; Tanaka T; Sogabe S; Matsumoto S; Yamaguchi M; Kimura H; Itoh F
    Bioorg Med Chem; 2008 Apr; 16(8):4715-32. PubMed ID: 18313304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydroxyl-terminated peptidomimetic inhibitors of neuronal nitric oxide synthase.
    Mbadugha BN; Seo J; Ji H; Martásek P; Roman LJ; Shea TM; Li H; Poulos TL; Silverman RB
    Bioorg Med Chem; 2006 Jun; 14(11):3681-90. PubMed ID: 16480878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery, synthesis and biological evaluation of isoquinolones as novel and highly selective JNK inhibitors (2).
    Asano Y; Kitamura S; Ohra T; Itoh F; Kajino M; Tamura T; Kaneko M; Ikeda S; Igata H; Kawamoto T; Sogabe S; Matsumoto S; Tanaka T; Yamaguchi M; Kimura H; Fukumoto S
    Bioorg Med Chem; 2008 Apr; 16(8):4699-714. PubMed ID: 18313930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyridazinodiazepines as a high-affinity, P2-P3 peptidomimetic class of interleukin-1 beta-converting enzyme inhibitor.
    Dolle RE; Prasad CV; Prouty CP; Salvino JM; Awad MM; Schmidt SJ; Hoyer D; Ross TM; Graybill TL; Speier GJ; Uhl J; Miller BE; Helaszek CT; Ator MA
    J Med Chem; 1997 Jun; 40(13):1941-6. PubMed ID: 9207934
    [No Abstract]   [Full Text] [Related]  

  • 17. Modeling caspase-1 inhibition: Implications for catalytic mechanism and drug design.
    Ramos-Guzmán CA; Zinovjev K; Tuñón I
    Eur J Med Chem; 2019 May; 169():159-167. PubMed ID: 30875506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The synthetic tellurium compound, AS101, is a novel inhibitor of IL-1beta converting enzyme.
    Brodsky M; Yosef S; Galit R; Albeck M; Longo DL; Albeck A; Sredni B
    J Interferon Cytokine Res; 2007 Jun; 27(6):453-62. PubMed ID: 17572009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of potent and specific fructose-1,6-bisphosphatase inhibitors and a series of orally-bioavailable phosphoramidase-sensitive prodrugs for the treatment of type 2 diabetes.
    Dang Q; Kasibhatla SR; Reddy KR; Jiang T; Reddy MR; Potter SC; Fujitaki JM; van Poelje PD; Huang J; Lipscomb WN; Erion MD
    J Am Chem Soc; 2007 Dec; 129(50):15491-502. PubMed ID: 18041834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Semicarbazone-based inhibitors of cathepsin K, are they prodrugs for aldehyde inhibitors?
    Adkison KK; Barrett DG; Deaton DN; Gampe RT; Hassell AM; Long ST; McFadyen RB; Miller AB; Miller LR; Payne JA; Shewchuk LM; Wells-Knecht KJ; Willard DH; Wright LL
    Bioorg Med Chem Lett; 2006 Feb; 16(4):978-83. PubMed ID: 16290936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.